Respiratory Pathogen Testing

Everyone is at risk of a respiratory infection. Respiratory infections are a leading cause of emergency room visits and hospitalization ranging from pediatric neonatal population to nursing home patients. Infections are predominantly caused by viruses but can appear similar to or overlap bacterial infections.  The SUPREME Respiratory Pathogen Panel (RPP) tests for a comprehensive set of 20 respiratory viral and bacterial pathogens in about an hour. The RPP identifies the most common viral and bacterial pathogens that cause respiratory tract infections with nearly indistinguishable symptoms. The rapid and accurate identification of the probable causative agents help determine how healthcare providers choose to treat a respiratory tract infection. Our multiplex PCR platform for respiratory pathogen infections targeting a 20 syndromic panel all in 1 test process provides fast, and comprehensive results for specific pathogens to help differentiate between these causing agents. Our rapid testing provides an overall 97.1% Sensitivity and 99.3% Specificity. The panel now includes SARS-CoV-2 guaranteeing a 98.4% PPA and 98.9% NPA. Our PCR technology is more sensitive than POC Antigen Assays and conventional cultures. This means your patients can receive the right treatment the first time, potentially leading to higher patient satisfaction and lower costs.

Benefits of Testing:

“An Asthmatic Patient like myself, it took a physical physician visits, chest x-ray, and multiple testing methods to detect one bacterial target. Initial suggest virtual appointment delayed the process even more. It took three days to detect and diagnose me with “Walking” pneumonia caused by mycoplasma pneumonia. The process was initiated with a required PCR COVID test before a physician could see me and then an in-person physician visit with physical testing, chest x-ray and then diagnosing.”- Angelica Rodriguez